XML 59 R38.htm IDEA: XBRL DOCUMENT

Inventory (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2023

Dec. 31, 2022

Dec. 31, 2021

Inventory [Abstract]

Schedule of Reconciliation of the Company’s Biological Assets

Set out below is a reconciliation of the Company’s biological assets as at June 30, 2023 and December 31, 2022:

As at,		June 30, 2023				December 31, 2022
Balance, beginning of the period		$	809,180			$	—
Acquisition (note 4)			—				200,457
Gain (loss) on change in fair value of biological assets			(562,045	)			580,411
Movement in exchange rate			10,009				28,312
Balance, end of the period		$	257,144			$	809,180

Set out below is a reconciliation of the Company’s biological assets as at December 31, 2022 and 2021:

For the years ended December 31,		2022			2021
Balance, beginning of the year		$	—		$	—
Requisition of raw materials from inventory			—			202,900
Capitalized costs			—			490,672
Acquisition (note 4)			200,457			—
Gain (loss) on change in fair value of biological assets			580,411			(693,572	)
Movement in exchange rate			28,312			—
		$	809,180		$	—

Set out below is a reconciliation of the Company’s biological assets as at December 31, 2021 and as at December 31, 2020:

For the period ended December 31		2021				2020
Balance, beginning of the period		$	—			$	—
Requisition of raw materials from inventory			202,900				—
Capitalized costs			490,672				—
Loss on change in fair value of biological assets			(693,572	)			—
		$	—			$	—